CAH Form 4: Officer Receives 54,537 Performance Share Units Settling Aug 15, 2025
Rhea-AI Filing Summary
Stephen M. Mason, an officer of Cardinal Health, Inc. (CAH), reported a non-cash acquisition on 08/12/2025. The filing shows 54,537 performance share units acquired that, per the explanatory note, will settle into common shares on August 15, 2025 at an effective price of $0. After this award, the report lists 89,514 shares beneficially owned following the transaction. The Form 4 was signed on behalf of the reporting person by an attorney-in-fact, James E. Barnett, on 08/12/2025. The filing identifies the reporting person as an officer with title shown as CEO, GMPD Segment.
Positive
- Acquired 54,537 performance share units that will settle into common shares on August 15, 2025, increasing reported beneficial ownership to 89,514 shares
- Timely Section 16 disclosure filed and signed (via attorney-in-fact) on 08/12/2025
Negative
- None.
Insights
TL;DR: Routine, non-cash PSU award increases an officer's ownership; governance impact is standard and not immediately market-moving.
The Form 4 documents an award of 54,537 performance share units that will settle into common shares on August 15, 2025. As a non-cash equity award, this changes beneficial ownership metrics but does not represent a market transaction or cash inflow/outflow. The filing was executed by an attorney-in-fact, which is common for insider reporting. From a governance perspective, the disclosure is timely and follows Section 16 reporting requirements; it does not, by itself, indicate any governance concerns.
TL;DR: Insider grant increases reported stake to 89,514 shares; the award settles later and carries no immediate cash impact.
The entry records 54,537 performance share units acquired on 08/12/2025 that will settle on August 15, 2025 and are shown at $0 price, consistent with compensation-based PSU awards. Beneficial ownership following the reported transaction is 89,514 shares. Because this is a compensation settlement rather than an open-market purchase or sale, it is unlikely to be material to Cardinal Health's public float or near-term share supply. The disclosure is precise about dates and settlement.